Vitrolife

120.10 SEK

+12.45 %

Less than 1K followers

VITR

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

+12.45 %
+36.55 %
-5.06 %
-12.34 %
-17.17 %
-21.25 %
-43.35 %
-60.55 %
+1,856.98 %

Vitrolife is an international group that provides medical devices and genetic services. The company develops and manufactures services and products for personalized genetic information as well as medical devices in the field of fertility. Vitrolife supports customers in their operations to improve patient outcomes from fertility treatments. Vitrolife's products and services are available globally. The company is headquartered in Gothenburg, Sweden.

Read more
Market cap
16.27B SEK
Turnover
166.87M SEK
Revenue
3.44B
EBIT %
-140.55 %
P/E
-
Dividend yield-%
0.92 %
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
23/4
2026

Interim report Q1'26

5/5
2026

General meeting '26

6/5
2026

Annual dividend

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.